Allergy Therapeutics PLC - Sussex-based biotechnology firm focused on allergy vaccines - Screens first patient in exploratory field study of Grass MATA MPL immunotherapy on patient who suffer from allergic symptoms when exposed to grass.
Current stock price: 13.29 pence
Year-to-date change: up 30%
By Eric Cunha; ericcunha@alliancenews.com
Copyright 2020 Alliance News Limited. All Rights Reserved.